- Home
- CRMT vs FULC Comparison
CRMT vs FULC Comparison
Compare CRMT & FULC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRMT
- FULC
- Stock Information
- Founded
- CRMT 1981
- FULC 2015
- Country
- CRMT United States
- FULC United States
- Employees
- CRMT N/A
- FULC N/A
- Industry
- CRMT Other Specialty Stores
- FULC Biotechnology: Pharmaceutical Preparations
- Sector
- CRMT Consumer Discretionary
- FULC Health Care
- Exchange
- CRMT Nasdaq
- FULC Nasdaq
- Market Cap
- CRMT 462.3M
- FULC 372.2M
- IPO Year
- CRMT N/A
- FULC 2019
- Fundamental
- Price
- CRMT $44.86
- FULC $6.48
- Analyst Decision
- CRMT Hold
- FULC Buy
- Analyst Count
- CRMT 1
- FULC 8
- Target Price
- CRMT $50.00
- FULC $7.13
- AVG Volume (30 Days)
- CRMT 83.9K
- FULC 477.2K
- Earning Date
- CRMT 09-04-2025
- FULC 07-29-2025
- Dividend Yield
- CRMT N/A
- FULC N/A
- EPS Growth
- CRMT N/A
- FULC N/A
- EPS
- CRMT 2.33
- FULC N/A
- Revenue
- CRMT $1,385,632,000.00
- FULC N/A
- Revenue This Year
- CRMT $7.60
- FULC N/A
- Revenue Next Year
- CRMT $6.37
- FULC N/A
- P/E Ratio
- CRMT $19.95
- FULC N/A
- Revenue Growth
- CRMT N/A
- FULC 2752.05
- 52 Week Low
- CRMT $36.40
- FULC $2.32
- 52 Week High
- CRMT $62.72
- FULC $9.30
- Technical
- Relative Strength Index (RSI)
- CRMT 47.15
- FULC 43.58
- Support Level
- CRMT $45.83
- FULC $6.35
- Resistance Level
- CRMT $47.37
- FULC $6.85
- Average True Range (ATR)
- CRMT 1.36
- FULC 0.32
- MACD
- CRMT 0.58
- FULC 0.01
- Stochastic Oscillator
- CRMT 63.83
- FULC 24.69
About CRMT America's Car-Mart Inc
America's Car-Mart Inc is an automotive retailer in the U.S. focused exclusively on the Integrated Auto Sales and Finance segment of the used car market. The company's operations are principally conducted through its two operating subsidiaries, America's Car Mart Inc and Colonial Auto Finance. It predominantly sells older model used vehicles and provides financing for substantially all of its customers. It earns revenue from the sale of used vehicles and in the majority of the cases a related service contract and an accident protection plan product, as well as interest income and late fees from the related financing.
About FULC Fulcrum Therapeutics Inc.
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.